doi: 10.3389/fonc.2026.1803259 Received 03 February 2026 Revised 13 April 2026 Accepted 16 April 2026 Published 08 May 2026 Volume 16 - 2026 Edited by Mohd Ahmar Rauf, Wayne State University, United States Reviewed by Anzar Abdul Mujeeb, University of Michigan, United States Anjali Sengar, University of Michigan, United States Updates Copyright 2026 Chen, Hang, Wen, Ren and Chen
Clear solutions should remain clear
Were giving your body time to adapt, and were identifying your therapeutic window where benefits are strong and side effects stay reasonable
While Semaglutide GLP-1 has proven successful, tirzepatide has shown even better results in clinical trials
The improvement was not overnight, and I am not claiming this is a magic cure
In our research, the percentage of patients reporting fatigue dropped from 44% at week 4 to 22% by week 8